Healthcare False Claims Act Cases Account for Two-Thirds of Fraud Recoveries in Federal Fiscal Year 2023
NASHVILLE, Tenn., Feb. 28, 2024 /PRNewswire-PRWeb/ -- The U.S. Department of Justice (DOJ) reported civil fraud recoveries of nearly $2.7 billion in fiscal year (FY) 2023, with two-thirds of those recoveries in the healthcare industry, according to the 12th annual Healthcare Fraud & Abuse Review published today by law firm Bass, Berry & Sims.
- In its 12th annual Healthcare Fraud & Abuse Review, Bass, Berry & Sims provides analysis of healthcare fraud enforcement actions and False Claims Act developments probing SCOTUS cases, opioid enforcement and other areas.
- -- Brian D. Roark
Qui tam lawsuits filed by whistleblowers under the False Claims Act continue to be a driving force behind the government's civil healthcare fraud enforcement efforts. - Other hot-button issues likely will include the intersection of the False Claims Act with cybersecurity issues and the Controlled Substances Act, among others."
- Providers should expect to see Controlled Substances Act compliance and the False Claims Act continue to intersect in enforcement actions.